Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Americans have mixed feelings about value of medical care

Americans generally agree science has improved the quality of healthcare, but the vast majority consider it unaffordable, according to a recent Pew Research Center survey.

Thumbnail

CMS cuts funding for marketplace navigators for 2nd consecutive year

CMS announced it will award $10 million to the Navigator Program starting in the fall of 2018—representing a sharp decrease from $63 million in 2016.

Thumbnail

Pfizer backs down on drug price increases, announces split into three businesses

Following attacks by President Trump on Twitter, drugmaker Pfizer backed down on its previously announced plan to raise drug prices on a number of prescriptions. Pfizer also announced Wednesday it will reorganize into three businesses, effective in 2019.

Thumbnail

Cost control is top of mind for healthcare CEOs in 2018

The No. 1 concern for healthcare executives is cost control, according to Advisory Board’s Annual Health Care CEO Survey.

Amazon’s OTC business offers pills at steep discount

Retail giant Amazon is selling over-the-counter (OTC) medicines at lower prices than its brick-and-mortar competitors.

Thumbnail

Trump’s Supreme Court nominee could face questions on healthcare record

Brett Kavanaugh, President Donald Trump’s pick to replace Supreme Court Justice Anthony Kennedy and a D.C. Appeals Court judge, will likely face questions on his healthcare record during confirmation hearings.

Thumbnail

CMS will allow participants to withdraw from new bundles in March 2019

CMS has announced participants in the Bundled Payment for Care Improvement (BPCI) Advanced model will be able to retroactively withdraw beginning in March 2019.

Trump attacks Pfizer after drug price increase

President Donald Trump lashed out at drug manufacturer Pfizer after the company raised prices for 100 drugs by an average of 9 percent, effective July 1.

Displaying 3393 - 3400 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup